Pharmacokinetic/pharmacodynamic modelling of the antimalarial effect of Actelion-451840 in an induced blood stage malaria study in healthy subjects.
about
Characterization of Novel Antimalarial Compound ACT-451840: Preclinical Assessment of Activity and Dose-Efficacy ModelingCRISPR-Cas9-modified pfmdr1 protects Plasmodium falciparum asexual blood stages and gametocytes against a class of piperazine-containing compounds but potentiates artemisinin-based combination therapy partner drugs.Controlled Human Malaria Infection: Applications, Advances and Challenges.malERA: An updated research agenda for diagnostics, drugs, vaccines, and vector control in malaria elimination and eradication.Targeting Channels and Transporters in Protozoan Parasite Infections.Assessing Plasmodium falciparum transmission in mosquito-feeding assays using quantitative PCR.
P2860
Pharmacokinetic/pharmacodynamic modelling of the antimalarial effect of Actelion-451840 in an induced blood stage malaria study in healthy subjects.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 April 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pharmacokinetic/pharmacodynami ...... ria study in healthy subjects.
@en
Pharmacokinetic/pharmacodynami ...... ria study in healthy subjects.
@nl
type
label
Pharmacokinetic/pharmacodynami ...... ria study in healthy subjects.
@en
Pharmacokinetic/pharmacodynami ...... ria study in healthy subjects.
@nl
prefLabel
Pharmacokinetic/pharmacodynami ...... ria study in healthy subjects.
@en
Pharmacokinetic/pharmacodynami ...... ria study in healthy subjects.
@nl
P2093
P2860
P356
P1476
Pharmacokinetic/pharmacodynami ...... aria study in healthy subjects
@en
P2093
Alexandre Mathis
Andreas Krause
Jasper Dingemanse
Jörg J Möhrle
Louise Marquart
P2860
P304
P356
10.1111/BCP.12962
P407
P577
2016-05-11T00:00:00Z